JCG Online retweetledi

👉🏼 Our study at @JCGjournal
demonstrates higher effectiveness of upadacitinib compared with ustekinumab in UC patients with prior anti-TNF exposure 📊, with lower 1-year corticosteroid use observed in the upadacitinib group (40.1% vs 48.5%) 💊
📚 journals.lww.com/jcge/abstract/…
@TandonKp @ElfertKhaled @MouhandMD @alkasabrah

English


